Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Ropivacaine
Homo sapiens
Drug Action Pathway
Ropivacaine an aminoamide analgesic is a racemic mixture of "S" and "R" enantiomers used for local anesthesia or for short term management of pain. Ropivacaine acts to block generation and propagation of action potentials by increasing the threshold for electrical excitation. This is done by blocking the sodium channel which causes a inhibits depolarization and decreases action potentials. Ropivacaine is metabolized in the liver by cytochrome P4501A through aromatic hydroxylation. The resulting metabolite 3-hydroxy ropivacaine is excreted by diruesis. Precaution should be taken with high systemic doses of ropivacaine which can effect the central nervous system and cardiovascular system.
References
Ropivacaine References
Hansen TG: Ropivacaine: a pharmacological review. Expert Rev Neurother. 2004 Sep;4(5):781-91. doi: 10.1586/14737175.4.5.781.
Pubmed: 15853505
Kuthiala G, Chaudhary G: Ropivacaine: A review of its pharmacology and clinical use. Indian J Anaesth. 2011 Mar;55(2):104-10. doi: 10.4103/0019-5049.79875.
Pubmed: 21712863
Owen MD, Dean LS: Ropivacaine. Expert Opin Pharmacother. 2000 Jan;1(2):325-36. doi: 10.1517/14656566.1.2.325.
Pubmed: 11249552
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Settings